We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Prime Minister Rishi Sunak's speech at the Society of Editors 25th Anniversary Conference in London.
ARIA will focus on projects with potential to produce transformative technological change, or a paradigm shift in an area of science. ARIA is an executive non-departmental public body, sponsored by the Department for Science, Innovation and Technology .
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Legislation title: Guidance on the application of Plant Protection Products (PPPs) for phytosanitary treatment of oak processionary moth (OPM).
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
How to use a crossover randomised controlled trial to evaluate your digital health product.
The Fund aims to create the opportunity to build strong partnerships between UK and Turkish scientists, researchers and institutions.
Information about COVID-19 and pregnancy from the Royal College of Obstretricians and Gynaecologists (RCOG).
Check the tariff classification for vitamin gummies.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Transcript of Minister Whately's speech at the Association of Directors of Adult Social Services (ADASS) spring seminar.
Survivors can be ostracized from their communities, shunned by their families, denied justice and cut off from support networks. This can prevent community reconciliation and wider post-conflict stabilisation which is why the focus of the PSVI over the coming years...
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
Find out if voluntary National Insurance contributions will boost your State Pension.
How to use a before-and-after study to evaluate your digital health product.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Information and guidance on a range of medical devices for users and patients.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.